Fidelity International’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-500,000	Closed	-$6.6M	–	999
2019 Q2	$6.6M	Buy	+500,000	New	+$6.6M	0.01%	508